BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025

  October 16, 2025

   · 

  1 min read
• Press Releases

  Atossa Therapeutics to Present at the Maxim Growth Summit 2025

  October 16, 2025

   · 

  2 min read
• Press Releases

  Clene to Participate in a Panel Discussion at the Maxim Growth Summit

  October 16, 2025

   · 

  1 min read
• Press Releases

  MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery

  October 16, 2025

   · 

  3 min read
• Press Releases

  Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros’ clinical-stage MASP-3 inhibitor zaltenibart (OMS906)

  October 16, 2025

   · 

  8 min read
• Press Releases

  Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025

  October 16, 2025

   · 

  2 min read
• Press Releases

  Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors

  October 16, 2025

   · 

  5 min read
• Press Releases

  Step Pharma announces completion of €38 million Series C financing

  October 16, 2025

   · 

  3 min read
• Press Releases

  Rezolute to Participate in Upcoming Investor Conferences - October 15, 2025

  October 16, 2025

   · 

  1 min read
• Press Releases

  Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119, Considering Combination Therapies

  October 16, 2025

   · 

  7 min read